Marimed (MRMD) Return on Capital Employed (2012 - 2026)
Marimed (MRMD) posted quarterly Return on Capital Employed of 1.2% for Q1 2026, down 115.0% year-over-year from 8.01% in Q1 2025, and up 81.17% quarter-over-quarter from 6.38% in Q4 2025.
Marimed (MRMD) Return on Capital Employed (2012 - 2026) Analysis & Trends
Marimed (MRMD) has reported Return on Capital Employed for 15 consecutive years, with 1.2% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 115.0% year-over-year to 1.2%; the TTM figure through Mar 2026 stood at 1.2% (down 115.0% YoY), while the FY2025 annual figure was 1.94%, down 366.0% from the prior year.
- Return on Capital Employed advanced to 1.2% in Q1 2026 per MRMD's latest filing, from 6.38% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 28.02% in Q1 2022 and bottomed at 6.38% in Q4 2025.
- Historically, Return on Capital Employed has averaged 7.78% across 5 years, with a median of 6.9% in 2024.
- Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 2190 bps — and 2026, when it sank 115 bps.
- Marimed's Return on Capital Employed stood at 16.7% in 2022, then slumped by 47 bps to 8.85% in 2023, then slumped by 80 bps to 1.79% in 2024, then tumbled by 457 bps to 6.38% in 2025, then surged by 81 bps to 1.2% in 2026.
- Business Quant data shows MRMD's Return on Capital Employed at 1.2% in Q1 2026, 6.38% in Q4 2025, and 0.79% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Marimed | 29.17 Mn | 20.73 Mn | 16.23 Mn | -1.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.76% |
| Mar 31, 2026 | -1.20% |
| Dec 31, 2025 | -6.38% |
| Sep 30, 2025 | 0.79% |
| Jun 30, 2025 | 0.07% |
| Mar 31, 2025 | -0.05% |
| Dec 31, 2024 | 1.79% |
| Sep 30, 2024 | 4.06% |
| Jun 30, 2024 | 5.28% |
| Mar 31, 2024 | 6.90% |
| Dec 31, 2023 | 8.85% |
| Sep 30, 2023 | 9.73% |
| Jun 30, 2023 | 11.10% |
| Mar 31, 2023 | 12.83% |
| Dec 31, 2022 | 16.70% |
| Sep 30, 2022 | 16.35% |
| Jun 30, 2022 | 17.41% |
| Mar 31, 2022 | 28.02% |
| Dec 31, 2021 | 28.73% |
| Sep 30, 2021 | 38.25% |